| |
Mountain View, CA, United States, 09/26/2008 – Based on its recent analysis of the cardiovascular image management systems market, Frost & Sullivan presents ProSolv CardioVascular, a FUJIFILM Company, with the 2008 North American Frost & Sullivan Award for Product Quality Leadership, in recognition of the quality of the products and services the company brings to the market.
The 2008 Product Quality Leadership Award is presented to the company that has demonstrated superior quality control over its competitors in product manufacturing. Quality control is an essential element to satisfy customers, increase repeat buying behavior, and assure long-term market survival. ProSolv CardioVascular maintains an edge in product quality, efficiency and usability of its solution, and continually garners outstanding customer appraisal.
Providing full web-based functionality, the ProSolv® CardioVascular CVIIS (cardiovascular image and information system) is a vendor- and hardware-neutral, software-only solution that offers true integration of all cardiovascular modalities. In conjunction with leading cardiologists, ProSolv CardioVascular has developed sophisticated applications for the viewing, analysis and reporting of clinical images and information. In addition to being a high performance system, ProSolv CardioVascular provides users with a single point of entry to instant image viewing and reporting. This structure enables clinicians and staff access to the information they need to work efficiently and decisively to deliver the best care possible to patients.
The acquisition of ProSolv CardioVascular by FUJIFILM Medical Systems and the subsequent seamless integration of ProSolv CardioVascular with Fujifilm's Synapse® PACS, have proven to be effective for both companies and their respective customers. In addition to the immense workflow and clinical advantages, the integration also delivers shared storage infrastructure and cost savings benefits for facilities utilizing both systems.
Throughout the acquisition and integration process, ProSolv CardioVascular's solutions have continued to achieve the highest customer satisfaction ratings and reviews in the industry. With backing from a long-term partner and higher brand recognition, ProSolv CardioVascular is poised for full-fledged market expansion and globalization.
“This highly strategic move has allowed Fujifilm to penetrate the cardiology space rapidly and successfully, and gain market share across all segments, including the largest hospital organizations,” explains Frost & Sullivan Industry Analyst Nadim Daher. “The continued growth in staff, revenue, mindshare, and market presence experienced in the cardiology business at Fujifilm since the January 2007 acquisition is a clear indicator of the ongoing momentum at ProSolv CardioVascular.”
Both ProSolv CardioVascular and Fujifilm foster a culture of vendor neutrality and undertake an open and proactive approach with regard to hardware independence, systems integration and system interoperability. This ability to integrate with other cardiology systems eliminates the duplication of data input, reducing the potential for human error and inherently optimizing the management of workflow. Additionally, since ProSolv CardioVascular utilizes a true common database, users can recall and view studies on demand. Fast online access to prior exams allows better throughput of treatment and reporting results; a paramount factor for improving physician productivity and patient care.
Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.
About ProSolv CardioVascular, a FUJIFILM Company
Founded in 1989 as Problem Solving Concepts, Inc. (“ProSolv”) and acquired by FUJIFILM Medical Systems in January 2007, the company is a leading provider of enterprise-level information management solutions for the clinical analysis and management of digital medical images for cardiology. ProSolv CardioVascular's software solutions (prosolv.com) consist of advanced reporting and image management software, comprehensive support services and third-party components. The ProSolv® CardioVascular Enterprise Image and Information Management solution improves physician productivity, enhances customer revenue opportunities, automates complex medical imaging workflow, and maximizes customers' return on investment in capital equipment and clinical information systems. The company is headquartered in Indianapolis, Indiana.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership™ empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.
|
jake.wengroff[.]frost.com 
